Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 408 followers
Latest posts
Last updated about 3 hours ago
Novo gains head start on Lilly with European Commission approval of Wegovy pill
about 3 hours ago
The European Commission has granted marketing authorization for Novo Nordisk’s Wegovy pill...
Sanofi opens new chapters in Pfizer, Moderna mRNA patent litigation sagas
about 3 hours ago
As Pfizer and Moderna have tied off certain threads in their separate...
Merck touts Keytruda front-line win in endometrial cancer subtype, marking a PD-1 first
about 3 hours ago
Merck & Co.’s almighty Keytruda has become the first PD-1 inhibitor to...
Buzzy Veradermics shows its oral minoxidil can tackle female pattern hair loss, too
about 7 hours ago
With a midstage peek at the data on Veradermics’ oral formulation of...
No patent protection for Stelara? No problem for J&J as Tremfya fills the void
about 7 hours ago
Johnson & Johnson reported its fifth straight quarter with revenue growth of...
Kelun scores sac-TMT win in first-line NSCLC population missing from Merck’s massive phase 3 program
about 8 hours ago
The clinical blueprint for Merck & Co.’s prized TROP2-directed antibody-drug conjugate, sac-TMT...
Sanofi teams up with Special Olympics Unified Football World, raises respiratory health awareness
about 11 hours ago
Two years after its central role in the Paris Olympics in France...
Insilico signs on with CDMO Bora in $2.5B AI drug discovery deal
about 12 hours ago
Generative AI specialist Insilico Medicine has teamed up with another biopharma company...
With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
1 day ago
The FDA has approved a new small molecule inhibitor from Celcuity with...
Director's Note on What to Expect at the 2026 Partnerships with Sites Summit
1 day ago
Senior Conference Director Kate Woda breaks down what attendees can expect at...
Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay
1 day ago
Dr. Rana McKay speaks to the ARANOTE trial of NUBEQA® (darolutamide) and...
Inside agency view: Havas SO on authenticity, connection and pushing back against the ‘sea of sameness’
1 day ago
In the second of a new series of interviews with top executives...